Endpoints for Validation of Tumour Markers for Recurrence Risk - Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581

被引：0
|
作者：
Mahmoud, N. N. [1 ]
Lopatin, M. [2 ]
Clark-Langone, K. [2 ]
Lee, M. [2 ]
Niedzwiecki, D. [3 ]
Venook, A. P. [4 ]
机构：
[1] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA
[2] Genom Hlth Inc, Med Oncol, Redwood City, CA USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70904-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [41] Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Li, Yinuo
    Hou, Xin
    Chen, Wei
    Wang, Shixuan
    Ma, Xiangyi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Yinuo Li
    Xin Hou
    Wei Chen
    Shixuan Wang
    Xiangyi Ma
    Scientific Reports, 13
  • [43] Internal Validation of Predictive Models for Recurrence-Free Survival and Risk of Recurrence in Patients with Figo Stages I–IV Cervical Cancer
    Jorge Cea García
    Francisco Márquez Maraver
    M. Carmen Rubio Rodríguez
    Laura Ríos-Pena
    Inmaculada Rodríguez Jiménez
    Indian Journal of Gynecologic Oncology, 2024, 22
  • [44] Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy
    van Erning, F. N.
    Janssen-Heijnen, M. L. G.
    Creemers, G. J.
    Pruijt, J. F. M.
    Maas, H. A. A. M.
    Lemmens, V. E. P. P.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 224 - 233
  • [45] Inflammatory Markers Predict Overall and Recurrence-Free Survival after Liver Transplantation for Hepatocellular Carcinoma.
    Forde, Justin
    Ismael, Media
    Cabrera, Roniel
    HEPATOLOGY, 2018, 68 : 542A - 542A
  • [46] Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?
    Hayes, Ian P.
    Milanzi, Elasma
    Gibbs, Peter
    Faragher, Ian
    Reece, Jeanette C.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 523 - 534
  • [47] Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
    Feng, Long-Hai
    Zhu, Yu-Yao
    Zhou, Jia-Min
    Wang, Miao
    Xu, Wei-Qi
    Zhang, Ti
    Mao, An-Rong
    Cong, Wen-Ming
    Dong, Hui
    Wang, Lu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)
    Furlanetto, J.
    Nekljudova, V.
    Schneeweiss, A.
    Thode, C.
    Denkert, C.
    Untch, M.
    Bassy, M.
    Karn, T.
    Fasching, P. A.
    Stickeler, E.
    Schem, C.
    Marme, F.
    Grischke, E. -M.
    van Mackelenbergh, M.
    Strik, D.
    Schmatloch, S.
    Mueller, V.
    Loibl, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 57 - +
  • [49] Impact of Chemotherapy-Induced Ovarian Failure (CIOF) on Disease-Free Survival (DFS) and Overall Survival (OS) in Young Women with Early Breast Cancer (EBC)
    Furlanetto, Jenny
    Nekljudova, Valentina
    Schneeweiss, Andreas
    Thode, Christian
    Denkert, Carsten
    Untch, Michael
    Bassy, Martina
    Karn, Thomas
    Fasching, Peter A.
    Stickeler, Elmar
    Schem, Christian
    Marme, Frederik
    Grischke, Eva-Maria
    van Mackelenbergh, Marion
    Strik, Dorninika
    Schmatloch, Sabine
    Mueller, Volkmar
    Loibl, Sibylle
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 6 - 6
  • [50] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN HER2 NEGATIVE (HER2-) PRIMARY BREAST CANCER (BC)
    McCrea, C.
    Chatzidaki, I
    Drane, E.
    McArthur, E.
    Beaver, S.
    Reason, T.
    Gulati, P.
    VALUE IN HEALTH, 2020, 23 : S425 - S425
12345